Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Pilot Study of Etanercept in Dermatomyositis


A Pilot Study of Etanercept in Dermatomyositis




The purpose of this study is to determine the safety and tolerability of etanercept in people with dermatomyositis.

Study Status: Active, not recruiting


Condition Intervention Phase
Dermatomyositis Drug: etanercept
Other: placebo

Verified by Brigham and Women`s Hospital August, 2009

Sponsored by: Brigham and Women`s Hospital
Information provided by: Brigham and Women`s Hospital identifier: NCT00282880

Study Type: Interventional

Study Design: Allocation: Randomized, Control: Placebo Control, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Cleveland Clinic, Department of Neurology, 9500 Euclid Ave/ S90
Cleveland, Ohio 44195
United States

Anthony Amato, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit
  Information obtained from on
Link to the current record.

Cleveland Clinic Mobile Site